International Patent: NOVEL LACTOBACILLUS FERMENTUM HEM20792 STRAIN, AND COMPOSITION COMPRISING STRAIN OR CULTURE THEREOF FOR PREVENTING OR TREATING CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)

GENEVA, June 24 -- HEM PHARMA INC. filed a patent application (KR2025/014405) for “NOVEL LACTOBACILLUS FERMENTUM HEM20792 STRAIN, AND COMPOSITION COMPRISING STRAIN OR CULTURE THEREOF FOR PREVENTING OR TREATING CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)”. With publication no. WO/2026/116714, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: A61K 35/747

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....